Sculati Wealth Management, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 3 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 7.4%.

Quarter-by-quarter ownership
Sculati Wealth Management, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$195,821
+39.3%
200,0000.0%0.10%
+32.0%
Q1 2023$140,574
+80228.0%
200,0000.0%0.08%
-23.5%
Q4 2022$175
-99.9%
200,0000.0%0.10%
-6.7%
Q3 2022$178,000
+4.7%
200,0000.0%0.10%
+8.2%
Q2 2022$170,000
-4.0%
200,0000.0%0.10%
+11.5%
Q1 2022$177,000
-3.3%
200,0000.0%0.09%
-1.1%
Q4 2021$183,000
+5.2%
200,0000.0%0.09%
-4.3%
Q3 2021$174,000200,0000.09%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$22,713,0005.56%
SILVERBACK ASSET MANAGEMENT LLC 7,707,000$6,912,0000.94%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,615,000$31,948,0000.74%
DeepCurrents Investment Group LLC 12,521,000$11,079,0000.34%
AGF Investments LLC 4,000,000$3,502,0000.29%
WATER ISLAND CAPITAL LLC 2,250,000$2,014,0000.10%
L & S Advisors Inc 935,000$829,0000.10%
Sculati Wealth Management, LLC 200,000$177,0000.09%
PALISADE CAPITAL MANAGEMENT, LP 3,192,000$2,816,0000.06%
Teton Advisors, Inc. 400,000$354,0000.06%
View complete list of PARATEK PHARMACEUTICALS INC shareholders